|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1998-6-19
|
|
pubmed:abstractText |
The purpose of this randomized double-blind, placebo-controlled study was to compare the efficacy and safety of fluoxetine plus group psychotherapy versus group psychotherapy alone in HIV-seropositive men (based on 1986 CDC classes II, III, and IV.C.2) who had been diagnosed with major depressive disorder (DSM-III-R).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0160-6689
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
217-24
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9632030-Adult,
pubmed-meshheading:9632030-Combined Modality Therapy,
pubmed-meshheading:9632030-Comorbidity,
pubmed-meshheading:9632030-Depressive Disorder,
pubmed-meshheading:9632030-Double-Blind Method,
pubmed-meshheading:9632030-Drug Administration Schedule,
pubmed-meshheading:9632030-Fluoxetine,
pubmed-meshheading:9632030-HIV Seropositivity,
pubmed-meshheading:9632030-Headache,
pubmed-meshheading:9632030-Humans,
pubmed-meshheading:9632030-Male,
pubmed-meshheading:9632030-Nausea,
pubmed-meshheading:9632030-Patient Dropouts,
pubmed-meshheading:9632030-Placebos,
pubmed-meshheading:9632030-Psychiatric Status Rating Scales,
pubmed-meshheading:9632030-Psychotherapy, Group,
pubmed-meshheading:9632030-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.
|
|
pubmed:affiliation |
University of California, San Diego, La Jolla 92093-0603, USA. szisook@ucsd.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
